tirzepatide forum FDA Grants a New Indication for Obesity Management Compounded Tirzepatide Source Research :

It is being studied for obesity and related metabolic conditions, including type 2 diabetes

By bypassing the digestive system, this therapy allows for higher therapeutic doses without gastrointestinal side effects, helping patients feel revitalized, supported, and rebalanced more quickly than oral supplementation alone

Thng hiu CodeAge (M)

It may take a while for the other drugs to gain traction unless there are dramatic marketing efforts for them or they have some obvious advantage (e.g., oral administration )

Its inexpensive

Managing Side Effects Both weight loss medications can cause side effects like nausea, vomiting, and diarrhoea